• Thyroid Cancer Gene Panel from FNA (Afirma®, ThyGenX/ThyraMIR, ThyroSeq v2, RosettaGX Reveal)
  • GSTP1, APC, RASSF1 Promoter Methylation Profiling (ConfirmMDx) for Prostate Cancer
  • HIV-1 Integrase Inhibitor Resistance by Sequencing
  • PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) Gene Mutation Analysis
  • Anthrax Lethal Toxin Neutralization Assay
  • Actinomyces Culture
  • Urea Nitrogen (BUN), Serum
  • Cyclospora Stain
  • Nickel/Creatinine Ratio, Random, Urine
  • Follicular Lymphoma, bcl-2/JH t(14;18), Real-time PCR, Blood
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Fabry Disease (GLA) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Fabry Disease (GLA) Gene Mutation Analysis
Medical Test

LOINC
Access to Fabry Disease (GLA) Gene Mutation Analysis is restricted.